The Importance of NT-ProBNP determination at first time observation in ambulatory heart failure patients in general cardiology setting

2008 ◽  
Vol 7 ◽  
pp. 84-84
Author(s):  
L SARGENTO ◽  
M LOPES
Keyword(s):  
Heart Failure ◽  
Heart Failure Patients ◽  
Time Observation ◽  
First Time

Telemonitoring of implantable devices as a tool to prevent the spread of COVID-19 pandemic

2020 ◽  
Vol 1 (54) ◽  
pp. 10-14
Author(s):  
Łukasz Pastwa ◽  
Agnieszka Galbierczyk ◽  
Janusz Bednarski ◽  
Paweł Basiukiewicz ◽  
Michał Majzner ◽  
...  
Keyword(s):  
Heart Failure ◽  
Remote Monitoring ◽  
Implantable Devices ◽  
Monitoring Systems ◽  
Office Visits ◽  
Transport Costs ◽  
Heart Failure Patients ◽  
Remote Monitoring Systems ◽  
Remote Care ◽  
First Time

Telemonitoring of implantable devices is a long known and established element of heart failure patients’ care. All companies that produce implantable devices also deliver remote monitoring systems. Clinical data show safety and efficacy in this kind of care. It prevents hospitalisations due heart failure exacerbations. It also allows to reduce costs of care by reducing the number of in office visits and transport costs. In COVID-19 pandemy time cardiologic associacions (including polish) recommend using remote monitoring systems to reduce the spreading of pandemy and the risk of infection in heart failure patients. Until now there was no possibility in the polish healthcare system to reimburse remote care. After Polish Health Ministry announcement this possibility appears for the first time. The Implantable Device Ambulance of Western Hospital in Grodzisk Mazowiecki has 88 patients with implanted ICDs and CRTDs under remote care. System Carelinc of Medtronic allowed the number of relevant clinical decisions. From March 2020 the patients in the telemonitoring group undergo remote visits which are reimbursed by the National Health Fund.

scholarly journals Biomarkers in Routine Heart Failure Clinical Care

2019 ◽  
Vol 5 (1) ◽  
pp. 50-56 ◽  
Author(s):  
Sunil K Nadar ◽  
Muhammed Mujtaba Shaikh
Keyword(s):  
Heart Failure ◽  
Natriuretic Peptides ◽  
Gold Standard ◽  
Clinical Condition ◽  
Clinical Care ◽  
The Other ◽  
Heart Failure Patients ◽  
First Time ◽  
Current Guidelines

Heart failure is a clinical condition with complex pathophysiology that involves many different processes. Diagnosis is often difficult in patients presenting for the first time with breathlessness. Many biomarkers have been identified that are elevated in heart failure and their role in assessing prognosis has also been investigated. However, at present the natriuretic peptides appear to be the gold standard biomarker against which the other biomarkers are compared. In this review we will examine the evidence behind the other biomarkers for use in heart failure patients and the current guidelines for their use.

P6338Discussing prognosis with heart failure patients; the view of the cardiologist

2019 ◽  
Vol 40 (Supplement_1) ◽  
Author(s):  
M H L Van Der Wal ◽  
L Hjelmfors ◽  
A Stromberg ◽  
T Jaarsma
Keyword(s):  
Heart Failure ◽  
Healthcare Professionals ◽  
Response Rate ◽  
Team Approach ◽  
Heart Failure Patients ◽  
Validated Questionnaire ◽  
Esc Guidelines ◽  
The Mean ◽  
Cognitive Problems ◽  
First Time

Abstract Background Discussing prognosis is advocated in recent Heart Failure (HF) ESC guidelines. However, there is a lot of discussion about roles, responsibilities and timing with regard to discussing prognosis with HF patients and their family. The purpose of this study was to describe the views of cardiologists with regard to discussing prognosis with HF patients, experienced barriers and how difficult it is to have such conversations. Methods A total of 275 cardiologists (125 in the Netherlands; 150 in Sweden) were invited by email to participate in a survey. The questionnaire was adapted from a validated questionnaire for HF-nurses consisting of 10 items on communicating prognosis. Participants were asked to select at which time they would discuss prognosis for the first time and which barriers they experience in these discussions. Finally, they were asked to rate how difficult it is to discuss prognosis on a scale from 1 (not difficult at all) to 10 (very difficult). Results A total of 88 cardiologists (43 Dutch; 45 Swedish; response rate 32%) participated in the study (mean age 49±10; 28% women). Most of the cardiologists (82%) stated that discussing prognosis should be discussed with all HF patients. In their view, this could be done by the own cardiologist (97%), but also by a cardiologist on the ward (72%), the HF nurse (51%) or the GP (28%). In total 47% stated that prognosis should be discussed when the patient is diagnosed and 18% answered that it should take place preferably at the first period of decompensation. Fifteen percent reported to discuss it only in case of a serious deterioration of the condition of the patient. There were no significant differences in views between Dutch and Swedish cardiologists. Most important barriers to discuss prognosis were “cognitive problems of the patient” (69%) and “too little time to discuss the topic” (64%). Other important barriers were `the patient is not ready for it' (60%) and “fear that the patient would be worried/lose hope” (50%). Although the mean reported difficulty in discussing prognosis was rather low (4,2±2), 34% of the cardiologists rated >6. Swedish cardiologists found it more difficult compared to their Dutch colleagues (3,7±2 vs. 4,7±2; p<0.05) Conclusion A considerable number of cardiologists suggested to discuss prognosis with all HF patients at the time the patient is diagnosed. Barriers to discuss this were related to the patient (cognitive problems, not ready to discuss), the organisation (lack of time) or the cardiologist (fear of making the patient worried or losing hope). Swedish cardiologists experienced discussing prognosis more difficult compared to Dutch cardiologist. Although most of the cardiologists reported that the responsible cardiologist should discuss prognosis with the patient, also other healthcare professionals (cardiologist on the ward, HF nurse, GP) could discuss this. A team approach to improve discussing prognosis with HF patients therefor seems important.

Sign in / Sign up

Export Citation Format

Share Document